Cleared Traditional

K232415 - Nalu Neurostimulation System for Peripheral Nerve Stimulation (FDA 510(k) Clearance)

Aug 2024
Decision
376d
Days
Class 2
Risk

K232415 is an FDA 510(k) clearance for the Nalu Neurostimulation System for Peripheral Nerve Stimulation. This device is classified as a Stimulator, Peripheral Nerve, Implanted (pain Relief) (Class II - Special Controls, product code GZF).

Submitted by Boston Scientific Neuromodulation (Valencia, US). The FDA issued a Cleared decision on August 21, 2024, 376 days after receiving the submission on August 11, 2023.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5870.

Submission Details

510(k) Number K232415 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 11, 2023
Decision Date August 21, 2024
Days to Decision 376 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code GZF — Stimulator, Peripheral Nerve, Implanted (pain Relief)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.5870